|
|
|
|
| LEADER |
01893naaaa2200421uu 4500 |
| 001 |
52833 |
| 005 |
20220214 |
| 020 |
|
|
|a 978-3-030-86076-9
|
| 020 |
|
|
|a 9783030860769
|
| 024 |
7 |
|
|a 10.1007/978-3-030-86076-9
|c doi
|
| 041 |
0 |
|
|h English
|
| 042 |
|
|
|a dc
|
| 100 |
1 |
|
|a von Eckardstein, Arnold
|e edt
|
| 856 |
|
|
|z Get fulltext
|u https://library.oapen.org/handle/20.500.12657/52833
|
| 700 |
1 |
|
|a Binder, Christoph J.
|e edt
|
| 700 |
1 |
|
|a von Eckardstein, Arnold
|e oth
|
| 700 |
1 |
|
|a Binder, Christoph J.
|e oth
|
| 245 |
1 |
0 |
|a Prevention and Treatment of Atherosclerosis : Improving State-of-the-Art Management and Search for Novel Targets
|
| 260 |
|
|
|a Cham
|b Springer Nature
|c 2022
|
| 300 |
|
|
|a 1 electronic resource (538 p.)
|
| 506 |
0 |
|
|a Open Access
|2 star
|f Unrestricted online access
|
| 520 |
|
|
|a This open access book is supported by the European Atherosclerosis Society Association (EAS). This follow-up edition of the well-received Handbook volume 'Atherosclerosis: Diet and Drugs' reflects the state-of-the-art and most recent developments in atherosclerosis research. Outstanding international experts give a comprehensive overview of the field covering topics, such as improving the treatment focusing on established targets, novel drug developments addressing pre-defined targets, hypothesis-based and hypothesis-free approaches to unravel novel targets.
|
| 540 |
|
|
|a Creative Commons
|
| 546 |
|
|
|a English
|
| 650 |
|
7 |
|a Cardiovascular medicine
|2 bicssc
|
| 650 |
|
7 |
|a Pharmacology
|2 bicssc
|
| 650 |
|
7 |
|a Metabolism
|2 bicssc
|
| 653 |
|
|
|a open access
|
| 653 |
|
|
|a prevention and treatment of atherosclerosis
|
| 653 |
|
|
|a cardiovascular disease
|
| 653 |
|
|
|a cardiovascular risk factors
|
| 653 |
|
|
|a vascular biology
|
| 653 |
|
|
|a diet and drugs
|
| 653 |
|
|
|a systems biology
|
| 653 |
|
|
|a lipoproteins
|
| 653 |
|
|
|a inflammation
|
| 653 |
|
|
|a thrombosis
|
| 653 |
|
|
|a lifestyle
|
